Dolby Laboratories, Inc.
US ˙ NYSE ˙ US25659T1079

SecurityDLB / Dolby Laboratories, Inc.
InstitutionShell Asset Management Co
Latest Disclosed Ownership212 shares
Latest Disclosed Value $ 15
Shell Asset Management Co reports 71.58% decrease in ownership of DLB / Dolby Laboratories, Inc.

On November 7, 2025 - Shell Asset Management Co filed a 13F-HR form disclosing ownership of 212 shares of Dolby Laboratories, Inc. (US:DLB) valued at $15,342 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 23, 2025 disclosing 746 shares of Dolby Laboratories, Inc.. The current value of the position is $11,456 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-07 2025-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 212 -534 -71.58 0 0.0015
2025-07-23 2025-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 746 -82 -9.90 0 0.0019
2025-05-14 2025-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 828 -35 -4.06 0 0.0031
2025-02-14 2024-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 863 0 0.00 0 0.0029
2024-11-07 2024-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 863 -53 -5.79 0 0.0029
2024-07-25 2024-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 916 -107 -10.46 0 0.0033
2024-02-14 2023-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 1,023 -299 -22.62 0 0.0041
2023-11-08 2023-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 1,322 -21 -1.56 0 0.0043
2023-07-28 2023-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 1,343 -1,479 -52.41 0 0.0044
2023-05-15 2023-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 2,822 -10 -0.35 0 0.0100
2023-02-07 2022-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 2,832 -576 -16.90 0 -100.00 0.0088
2022-11-14 2022-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 3,408 -891 -20.73 222 -27.92 0.0087
2022-08-09 2022-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 4,299 8 0.19 308 -8.33 0.0091
2022-05-04 2022-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 4,291 -635 -12.89 336 -28.36 0.0079
2022-02-09 2021-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 4,926 26 0.53 469 8.82 0.0096
2021-11-04 2021-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 4,900 974 24.81 431 11.66 0.0097
2021-08-12 2021-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 3,926 210 5.65 386 5.18 0.0075
2021-05-10 2021-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 3,716 0 0.00 367 1.66 0.0073
2021-02-16 2020-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 3,716 -2,453 -39.76 361 -11.74 0.0075
2020-11-13 2020-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 6,169 0 0.00 409 0.74 0.0095
2020-08-10 2020-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 6,169 -74 -1.19 406 20.12 0.0101
2020-05-11 2020-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 6,243 -95 -1.50 338 -22.48 0.0094
2020-02-13 2019-12-31 13F DOLBY LABORATORIES COM CL A 25659T107 6,338 -145 -2.24 436 4.06 0.0094
2019-11-12 2019-09-30 13F DOLBY LABORATORIES COM CL A 25659T107 6,483 -56 -0.86 419 -0.71 0.0096
2019-08-12 2019-06-30 13F DOLBY LABORATORIES COM CL A 25659T107 6,539 -150 -2.24 422 0.24 0.0093
2019-05-09 2019-03-31 13F DOLBY LABORATORIES COM CL A 25659T107 6,689 0 0.00 421 1.69 0.0093
2019-02-13 2018-12-31 13F DOLBY LABORATORIES COM 25659T107 6,689 -600 -8.23 414 -18.82 0.0103
2018-11-13 2018-09-30 13F DOLBY LABORATORIES COM 25659T107 7,289 0 0.00 510 13.33 0.0101
2018-08-10 2018-06-30 13F DOLBY LABORATORIES COM 25659T107 7,289 -390 -5.08 450 -7.79 0.0092
2018-05-14 2018-03-31 13F DOLBY LABORATORIES COM 25659T107 7,679 0 0.00 488 2.52 0.0097
2018-02-09 2017-12-31 13F DOLBY LABORATORIES COM 25659T107 7,679 7,670 85,222.22 476 0.0094
2013-10-28 2013-09-30 13F DOLBY LABORATORIES COM 25659T107 9 0 0.00 0 0.0000
2013-08-01 2013-06-30 13F DOLBY LABORATORIES COM 25659T107 9 9 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.